Share Price and Basic Stock Data
Last Updated: November 8, 2025, 4:21 am
| PEG Ratio | -57.77 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Uravi Defence & Technology Ltd operates in the Auto Ancillary Equipment Lamp industry, with its share price standing at ₹238 and a market capitalization of ₹271 Cr. The company’s revenue for the fiscal year ending March 2025 was reported at ₹43.63 Cr, with a trailing twelve-month (TTM) revenue of ₹42.56 Cr. Quarterly sales figures showed fluctuations, with the highest sales of ₹11.40 Cr recorded in March 2025, while the lowest was ₹10.02 Cr in both December 2024 and June 2025. This revenue trend indicates a degree of volatility, which may be influenced by seasonal demand patterns or operational challenges. The operating profit margin (OPM) for March 2025 was reported at 13.25%, reflecting the company’s ability to manage its costs relative to its sales. Overall, Uravi’s revenue performance demonstrates a growing business, albeit with some inconsistencies in quarterly sales that warrant further analysis.
Profitability and Efficiency Metrics
In terms of profitability, Uravi Defence reported a net profit of ₹2.55 Cr for the fiscal year ending March 2025, resulting in a net profit margin of 4.46%. The operating profit for the same period stood at ₹5.78 Cr, indicating effective cost management with an OPM of 13.25%. However, the company’s price-to-earnings (P/E) ratio of 116 suggests that it is trading at a premium compared to typical industry averages, which may indicate high investor expectations or overvaluation. The cash conversion cycle (CCC) was reported at 511.92 days, significantly higher than industry norms, which could suggest inefficiencies in inventory management and receivables collection. Moreover, the interest coverage ratio (ICR) of 3.54x indicates that the company comfortably meets its interest obligations, although the high CCC poses a risk to operational liquidity.
Balance Sheet Strength and Financial Ratios
Uravi Defence’s balance sheet reflects a total assets value of ₹88.77 Cr, with total borrowings at ₹25.88 Cr, resulting in a total debt-to-equity ratio of 0.48x. This level of leverage is relatively moderate, suggesting a balanced approach to financing. The company holds reserves of ₹35.10 Cr, providing a cushion for future growth or unforeseen challenges. The book value per share is reported at ₹46.91, while the price-to-book value (P/BV) ratio stands at 7.47x, indicating that the stock may be overvalued compared to its tangible book value. Key financial ratios such as return on equity (ROE) at 4.81% and return on capital employed (ROCE) at 8.54% illustrate the company’s efficiency in generating profits from its equity and capital, although these figures are relatively low compared to industry standards. The current ratio of 1.90x indicates adequate short-term liquidity, while the quick ratio of 1.11x suggests that the company is also managing its immediate liabilities effectively.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Uravi Defence shows a significant promoter holding of 70.30% as of March 2025, suggesting strong insider confidence in the company’s prospects. Foreign institutional investors (FIIs) increased their stake to 6.47%, up from 4.82% in March 2025, reflecting growing interest from external investors. Conversely, the public shareholding stood at 23.23%, which shows a slight decline from previous quarters, indicating potential concerns among retail investors. The number of shareholders increased to 2,576 by March 2025, highlighting a growing interest in the company. Such a rise in shareholder numbers, combined with a stable promoter holding, typically bodes well for investor sentiment and confidence. However, the decreasing public shareholding may warrant attention, as it could indicate a shift in investor perception regarding the company’s future performance.
Outlook, Risks, and Final Insight
Looking ahead, Uravi Defence & Technology Ltd faces both opportunities and challenges. The company’s strong promoter backing and increasing FII participation may bolster its market position. However, the high cash conversion cycle and elevated P/E ratio pose risks that could affect investor sentiment. Additionally, the company must address operational inefficiencies, particularly in inventory management, to enhance profitability. The competitive landscape in the auto ancillary sector also necessitates continuous innovation and adaptation to market demands. Should Uravi manage to streamline its operations and improve its efficiency metrics, it may enhance its financial performance and shareholder value. Conversely, failure to address these operational challenges could lead to volatility in revenue and profitability, potentially impacting its stock performance in the long run.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Uravi Defence & Technology Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Varroc Engineering Ltd | 9,791 Cr. | 641 | 666/365 | 51.9 | 102 | 0.16 % | 17.1 % | 7.37 % | 1.00 |
| Uravi Defence & Technology Ltd | 249 Cr. | 219 | 588/213 | 107 | 41.2 | 0.00 % | % | % | 10.0 |
| Lumax Industries Ltd | 4,292 Cr. | 4,591 | 5,358/1,960 | 28.8 | 873 | 0.76 % | 16.4 % | 19.3 % | 10.0 |
| Fiem Industries Ltd | 5,544 Cr. | 2,106 | 2,276/1,156 | 26.3 | 394 | 1.42 % | 27.8 % | 21.0 % | 10.0 |
| Industry Average | 4,969.00 Cr | 1,889.25 | 53.50 | 352.55 | 0.59% | 20.43% | 15.89% | 7.75 |
Quarterly Result
| Metric | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|
| Sales | 11.12 | 10.02 | 11.40 | 10.02 |
| Expenses | 9.62 | 9.08 | 9.65 | 8.80 |
| Operating Profit | 1.50 | 0.94 | 1.75 | 1.22 |
| OPM % | 13.49% | 9.38% | 15.35% | 12.18% |
| Other Income | 0.07 | 0.37 | 0.33 | 0.40 |
| Interest | 0.57 | 0.40 | 0.39 | 0.39 |
| Depreciation | 0.55 | 0.55 | 0.51 | 0.52 |
| Profit before tax | 0.45 | 0.36 | 1.18 | 0.71 |
| Tax % | 33.33% | 25.00% | 31.36% | 25.35% |
| Net Profit | 0.35 | 0.71 | 0.93 | 0.53 |
| EPS in Rs | 0.32 | 0.65 | 0.76 | 0.39 |
Last Updated: August 20, 2025, 1:45 am
Below is a detailed analysis of the quarterly data for Uravi Defence & Technology Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 10.02 Cr.. The value appears to be declining and may need further review. It has decreased from 11.40 Cr. (Mar 2025) to 10.02 Cr., marking a decrease of 1.38 Cr..
- For Expenses, as of Jun 2025, the value is 8.80 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 9.65 Cr. (Mar 2025) to 8.80 Cr., marking a decrease of 0.85 Cr..
- For Operating Profit, as of Jun 2025, the value is 1.22 Cr.. The value appears to be declining and may need further review. It has decreased from 1.75 Cr. (Mar 2025) to 1.22 Cr., marking a decrease of 0.53 Cr..
- For OPM %, as of Jun 2025, the value is 12.18%. The value appears to be declining and may need further review. It has decreased from 15.35% (Mar 2025) to 12.18%, marking a decrease of 3.17%.
- For Other Income, as of Jun 2025, the value is 0.40 Cr.. The value appears strong and on an upward trend. It has increased from 0.33 Cr. (Mar 2025) to 0.40 Cr., marking an increase of 0.07 Cr..
- For Interest, as of Jun 2025, the value is 0.39 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.39 Cr..
- For Depreciation, as of Jun 2025, the value is 0.52 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.51 Cr. (Mar 2025) to 0.52 Cr., marking an increase of 0.01 Cr..
- For Profit before tax, as of Jun 2025, the value is 0.71 Cr.. The value appears to be declining and may need further review. It has decreased from 1.18 Cr. (Mar 2025) to 0.71 Cr., marking a decrease of 0.47 Cr..
- For Tax %, as of Jun 2025, the value is 25.35%. The value appears to be improving (decreasing) as expected. It has decreased from 31.36% (Mar 2025) to 25.35%, marking a decrease of 6.01%.
- For Net Profit, as of Jun 2025, the value is 0.53 Cr.. The value appears to be declining and may need further review. It has decreased from 0.93 Cr. (Mar 2025) to 0.53 Cr., marking a decrease of 0.40 Cr..
- For EPS in Rs, as of Jun 2025, the value is 0.39. The value appears to be declining and may need further review. It has decreased from 0.76 (Mar 2025) to 0.39, marking a decrease of 0.37.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 4:12 am
| Metric | Mar 2025 | TTM |
|---|---|---|
| Sales | 43.63 | 42.56 |
| Expenses | 37.85 | 37.15 |
| Operating Profit | 5.78 | 5.41 |
| OPM % | 13.25% | 12.71% |
| Other Income | 0.97 | 1.17 |
| Interest | 1.91 | 1.75 |
| Depreciation | 2.05 | 2.13 |
| Profit before tax | 2.79 | 2.70 |
| Tax % | 30.11% | |
| Net Profit | 2.55 | 2.52 |
| EPS in Rs | 2.18 | 2.10 |
| Dividend Payout % | 0.00% |
YoY Net Profit Growth
| Year |
|---|
| YoY Net Profit Growth (%) |
| Change in YoY Net Profit Growth (%) |
No data available for trend analysis.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 49% |
| 3 Years: | 44% |
| 1 Year: | -25% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | % |
Last Updated: September 5, 2025, 1:50 pm
Balance Sheet
Last Updated: August 9, 2025, 9:53 am
| Month | Mar 2025 |
|---|---|
| Equity Capital | 11.26 |
| Reserves | 35.10 |
| Borrowings | 25.88 |
| Other Liabilities | 16.53 |
| Total Liabilities | 88.77 |
| Fixed Assets | 19.58 |
| CWIP | 2.71 |
| Investments | 0.19 |
| Other Assets | 66.29 |
| Total Assets | 88.77 |
Below is a detailed analysis of the balance sheet data for Uravi Defence & Technology Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 11.26 Cr.. No previous period data is available for comparison.
- For Reserves, as of Mar 2025, the value is 35.10 Cr.. No previous period data is available for comparison.
- For Borrowings, as of Mar 2025, the value is 25.88 Cr.. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. No previous period data is available for comparison.
- For Other Liabilities, as of Mar 2025, the value is 16.53 Cr.. No previous period data is available for comparison.
- For Total Liabilities, as of Mar 2025, the value is 88.77 Cr.. No previous period data is available for comparison.
- For Fixed Assets, as of Mar 2025, the value is 19.58 Cr.. No previous period data is available for comparison.
- For CWIP, as of Mar 2025, the value is 2.71 Cr.. No previous period data is available for comparison.
- For Investments, as of Mar 2025, the value is 0.19 Cr.. No previous period data is available for comparison.
- For Other Assets, as of Mar 2025, the value is 66.29 Cr.. No previous period data is available for comparison.
- For Total Assets, as of Mar 2025, the value is 88.77 Cr.. No previous period data is available for comparison.
Notably, the Reserves (35.10 Cr.) exceed the Borrowings (25.88 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2025 |
|---|---|
| Free Cash Flow | -20.10 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2025 |
|---|---|
| Debtor Days | 119.97 |
| Inventory Days | 453.33 |
| Days Payable | 61.37 |
| Cash Conversion Cycle | 511.92 |
| Working Capital Days | 122.81 |
| ROCE % |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 |
|---|---|
| FaceValue | 10.00 |
| Basic EPS (Rs.) | 2.31 |
| Diluted EPS (Rs.) | 2.25 |
| Cash EPS (Rs.) | 3.55 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 46.91 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 46.91 |
| Revenue From Operations / Share (Rs.) | 38.75 |
| PBDIT / Share (Rs.) | 5.99 |
| PBIT / Share (Rs.) | 4.17 |
| PBT / Share (Rs.) | 2.48 |
| Net Profit / Share (Rs.) | 1.73 |
| NP After MI And SOA / Share (Rs.) | 2.26 |
| PBDIT Margin (%) | 15.46 |
| PBIT Margin (%) | 10.76 |
| PBT Margin (%) | 6.39 |
| Net Profit Margin (%) | 4.46 |
| NP After MI And SOA Margin (%) | 5.83 |
| Return on Networth / Equity (%) | 4.81 |
| Return on Capital Employeed (%) | 8.54 |
| Return On Assets (%) | 2.86 |
| Long Term Debt / Equity (X) | 0.02 |
| Total Debt / Equity (X) | 0.48 |
| Current Ratio (X) | 1.90 |
| Quick Ratio (X) | 1.11 |
| Interest Coverage Ratio (X) | 3.54 |
| Interest Coverage Ratio (Post Tax) (X) | 2.02 |
| Enterprise Value (Cr.) | 404.69 |
| EV / Net Operating Revenue (X) | 9.28 |
| EV / EBITDA (X) | 59.98 |
| MarketCap / Net Operating Revenue (X) | 9.05 |
| Price / BV (X) | 7.47 |
| Price / Net Operating Revenue (X) | 9.05 |
| EarningsYield | 0.01 |
After reviewing the key financial ratios for Uravi Defence & Technology Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. No previous period data is available for comparison.
- For Basic EPS (Rs.), as of Mar 25, the value is 2.31. This value is below the healthy minimum of 5. No previous period data is available for comparison.
- For Diluted EPS (Rs.), as of Mar 25, the value is 2.25. This value is below the healthy minimum of 5. No previous period data is available for comparison.
- For Cash EPS (Rs.), as of Mar 25, the value is 3.55. This value is within the healthy range. No previous period data is available for comparison.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 46.91. No previous period data is available for comparison.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 46.91. No previous period data is available for comparison.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 38.75. No previous period data is available for comparison.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 5.99. This value is within the healthy range. No previous period data is available for comparison.
- For PBIT / Share (Rs.), as of Mar 25, the value is 4.17. This value is within the healthy range. No previous period data is available for comparison.
- For PBT / Share (Rs.), as of Mar 25, the value is 2.48. This value is within the healthy range. No previous period data is available for comparison.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 1.73. This value is below the healthy minimum of 2. No previous period data is available for comparison.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 2.26. This value is within the healthy range. No previous period data is available for comparison.
- For PBDIT Margin (%), as of Mar 25, the value is 15.46. This value is within the healthy range. No previous period data is available for comparison.
- For PBIT Margin (%), as of Mar 25, the value is 10.76. This value is within the healthy range. No previous period data is available for comparison.
- For PBT Margin (%), as of Mar 25, the value is 6.39. This value is below the healthy minimum of 10. No previous period data is available for comparison.
- For Net Profit Margin (%), as of Mar 25, the value is 4.46. This value is below the healthy minimum of 5. No previous period data is available for comparison.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 5.83. This value is below the healthy minimum of 8. No previous period data is available for comparison.
- For Return on Networth / Equity (%), as of Mar 25, the value is 4.81. This value is below the healthy minimum of 15. No previous period data is available for comparison.
- For Return on Capital Employeed (%), as of Mar 25, the value is 8.54. This value is below the healthy minimum of 10. No previous period data is available for comparison.
- For Return On Assets (%), as of Mar 25, the value is 2.86. This value is below the healthy minimum of 5. No previous period data is available for comparison.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.02. This value is below the healthy minimum of 0.2. No previous period data is available for comparison.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.48. This value is within the healthy range. No previous period data is available for comparison.
- For Current Ratio (X), as of Mar 25, the value is 1.90. This value is within the healthy range. No previous period data is available for comparison.
- For Quick Ratio (X), as of Mar 25, the value is 1.11. This value is within the healthy range. No previous period data is available for comparison.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 3.54. This value is within the healthy range. No previous period data is available for comparison.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 2.02. This value is below the healthy minimum of 3. No previous period data is available for comparison.
- For Enterprise Value (Cr.), as of Mar 25, the value is 404.69. No previous period data is available for comparison.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 9.28. This value exceeds the healthy maximum of 3. No previous period data is available for comparison.
- For EV / EBITDA (X), as of Mar 25, the value is 59.98. This value exceeds the healthy maximum of 15. No previous period data is available for comparison.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 9.05. This value exceeds the healthy maximum of 3. No previous period data is available for comparison.
- For Price / BV (X), as of Mar 25, the value is 7.47. This value exceeds the healthy maximum of 3. No previous period data is available for comparison.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 9.05. This value exceeds the healthy maximum of 3. No previous period data is available for comparison.
- For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. No previous period data is available for comparison.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Uravi Defence & Technology Ltd:
- Net Profit Margin: 4.46%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 8.54% (Industry Average ROCE: 20.43%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 4.81% (Industry Average ROE: 15.89%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 2.02
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.11
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 107 (Industry average Stock P/E: 53.5)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.48
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 4.46%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Auto Ancl - Equipment Lamp | Shop No. 329 Avior, Nirmal Galaxy, Mumbai Maharashtra 400080 | info@uravilamps.com http://www.uravilamps.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Niraj Damji Gada | Managing Director & CEO |
| Mr. Kaushik Damji Gada | WholeTime Director & CFO |
| Mr. Brijesh Aggarwal | Non Executive Director |
| Ms. Shreya Ramkrishnan | Ind. Non-Executive Director |
| Mr. Sreedhar Ramachandran Ayalur | Ind. Non-Executive Director |
| Mr. Niken Shah | Ind. Non-Executive Director |
FAQ
What is the intrinsic value of Uravi Defence & Technology Ltd?
Uravi Defence & Technology Ltd's intrinsic value (as of 08 November 2025) is 539.59 which is 146.39% higher the current market price of 219.00, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's 249 Cr. market cap, FY2025-2026 high/low of 588/213, reserves of ₹35.10 Cr, and liabilities of 88.77 Cr.
What is the Market Cap of Uravi Defence & Technology Ltd?
The Market Cap of Uravi Defence & Technology Ltd is 249 Cr..
What is the current Stock Price of Uravi Defence & Technology Ltd as on 08 November 2025?
The current stock price of Uravi Defence & Technology Ltd as on 08 November 2025 is 219.
What is the High / Low of Uravi Defence & Technology Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Uravi Defence & Technology Ltd stocks is 588/213.
What is the Stock P/E of Uravi Defence & Technology Ltd?
The Stock P/E of Uravi Defence & Technology Ltd is 107.
What is the Book Value of Uravi Defence & Technology Ltd?
The Book Value of Uravi Defence & Technology Ltd is 41.2.
What is the Dividend Yield of Uravi Defence & Technology Ltd?
The Dividend Yield of Uravi Defence & Technology Ltd is 0.00 %.
What is the ROCE of Uravi Defence & Technology Ltd?
The ROCE of Uravi Defence & Technology Ltd is %.
What is the ROE of Uravi Defence & Technology Ltd?
The ROE of Uravi Defence & Technology Ltd is %.
What is the Face Value of Uravi Defence & Technology Ltd?
The Face Value of Uravi Defence & Technology Ltd is 10.0.